Prevalence of osteoporosis and vertebral fractures in acromegalic patients

Clinical Cases in Mineral and Bone Metabolism

Volumn 8, Issue 3, 2011, Pages 37-43

  Padova, Giuseppina ^a   Borzì, Graziella ^a   Incorvaia, Laura ^a   Siciliano, Guido ^b   Migliorino, Valentina ^a   Vetri, Mario ^a   Tita, Patrizia ^a  

^a Garibaldi Nesima Hospital   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acromegaly; Osteoporosis

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; GROWTH HORMONE; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN;

ACROMEGALY; ADULT; ARTICLE; BONE DENSITY; BONE MALFORMATION; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; GENDER; GONAD; HUMAN; HYPOGONADISM; LUMBAR SPINE; MALE; MORBIDITY; MORTALITY; OSSIFICATION; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHALANX; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SCREENING; SPINE RADIOGRAPHY; SURVIVAL; THORACIC SPINE; VERTEBRA FRACTURE;

EID: 84856083083     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. White HD, Ahmad AM, Durham BH, Patwala A, Whittingham P, Fraser WD, Vora JP. Growth Hormone Replacement is important for the Restoration of Parathyroid Hormone sensitivity and Improvement in Bone Metabolism in Older Adult Growth Hormone-Deficient Patients. JCEM 2005, 90 (6):3371-3380. (Pubitemid 41014300)
2. Andreassen TT, Oxlund H. The effect of GH on cortical and cancellous bone. J Muscoloskel Neuron Interact 2001, 2 (1):49-58.
3. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors and the skeleton. Endocr Rev 2008, 29:535-559.
4. Ueland T. GH/IGF-1 and bone resorption in vivo and in vitro. European Journal of Endocrinology 2005, 152:327-332. (Pubitemid 40439482)
5. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr Rev 2004, 25: 102-52. (Pubitemid 38269977)
6. Jean Ho P, Lorraine M, Barkan A, Shapiro B. Bone mineral density of the Axial Skeleton in Acromegaly. J Nucl Med, 1992, 33:1608-1612.
7. Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly. Eur J Endocrinol 2005, 152:53-60. (Pubitemid 40185453)
8. Bonadonna S, Mazziotti G, Nuzzo M, et al. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in post-menopausal women. J Bone Miner Res 2005, 20:1837-44. (Pubitemid 41361885)
9. Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V, Scillitani A. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin Endocrinol (Oxf). 2009 Mar; 70(3):378-82.
10. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest. 1982, 69(6):1302-9. (Pubitemid 12081058)
11. Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J. Serum GH and IGF1 are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Eur J Endocrinol 2006, 155:709-715. (Pubitemid 44857495)
12. Scillitani A, Battista C, Chiodini I, et al. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin Endocrinol 2003, 58:725-731. (Pubitemid 36702732)
13. Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F, Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly. Eur J Endocrinol 2005, 152:53-60. (Pubitemid 40185453)
14. Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A. Prevalence of vertebral fractures in men with acromegaly. JCEM 2008, 93 (12): 4649-4655.
15. Bonadonna S, Mazziotti G, Nuzzo M, et al. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in post-menopausal women. J Bone Miner Res 2005, 20:1837-44. (Pubitemid 41361885)
16. Genant H. et al. J Bone Miner Res. 1993, 8:137-42.
17. Ezzat et al. Biochemical Assessment of Bone Formation and Resorption in Acromegaly. JCEM 1993, 78:1552-1457.
18. Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ. Pegvisomant- induced serum insulin-like growth factor-1 normalization in patients with acromegaly returns elevated markers of bone turnover to normal. J Clin Endocrinol Metab 2003, 88:5650-5655. (Pubitemid 38033029)
19. White et al. Effect of Active Acromegaly and Its treatment on Parathyroid Circadian Rhythmicity and Parathyroid Target-Organ Sensitivity. JCEM 2005, 91 (3):913-919. (Pubitemid 43357758)
20. Cappelli C, Gandossi E, Agosti B, Cerudelli B, Cumetti D, Castellano M, Pirola I, De Martino E, Rosei E. Long term treatment of acromegaly with Lanreotide: evidence of increased serum parathormone concentration. Endocr J 2004, 51(6):517-520. (Pubitemid 40209017)